Development of a Novel, Allogeneic GPRC5D-Directed CAR for Treatment of Multiple Myeloma PatientsJeremy M. Kinder, Terry J. Fry, Garrett Zipp et al.|Blood|2023Cited by 3
Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell TherapyVandana Chaturvedi, Terry J. Fry, Jesse Green et al.|Blood|2023Cited by 3
Identification of Healthy Donor Phenotypic and Functional Signatures That Predict Allogeneic, Hypoimmune CD19-Directed CAR T Cell PotencyDarin Salloum, Terry J. Fry, Kavita Tundwal et al.|Blood|2023Cited by 0